BST/HM6A (BST/HM6A)

Stuttgart Stock Exchange: BST/HM6A · EUR

€3.42

+0.06 (+1.8%)· Recorded snapshot

Market cap	2.5B
Revenue (ttm)	1.5B
Net income (ttm)	295.4M
EPS (ttm)	€0.45
P/E (trailing)	7.7x
P/E (forward)	7.4x
Dividend	€0.15 (4.43%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.5B
Net income (ttm): 295.4M
EPS (ttm): €0.45
P/E (trailing): 7.7x
P/E (forward): 7.4x
Market cap: 2.5B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E7.4

P25 13.5P50 19.1P75 28.3

Trailing P/E7.7

P25 14.1P50 23.7P75 38.5

ROE13.2

P25 -50.4P50 0.5P75 12

ROIC12.2

P25 -29.8P50 1.9P75 10.7

Benchmarks · 1M

All BST/HM6A indicators

Market & fundamental data

Available fields

248

Groups with data

Currency

BRL

Showing 248 of 248 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Brazil
Country code	DE
Earnings date	2026-10-27
Employees	10,564
Employees change	180
Employees growth	1.75%
Enterprise value	EUR 3.6B
Exchange	Stuttgart Stock Exchange
Financial currency	BRL
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1999
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	US44914U1060
Last earnings date	2026-10-27
Last refreshed	2026-10-28
Market cap	EUR 2.5B
Next earnings date	2027-03-12
Price	EUR 3.42
Price currency	EUR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	bst/HM6A
Website	https://www.hypera.com.br

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	18.34x
Average P/E ratio (3Y)	12.97x
Average P/E ratio (5Y)	14.26x
Earnings yield	13.06%
EV/Earnings	12.05x
EV/EBIT	8.42x
EV/EBITDA	7.57x
EV/FCF	8.32x
EV/Sales	2.41x
FCF / EV yield	12.01%
FCF yield	16.87%
Forward P/E	7.36x
Graham number	5.43126
Graham upside	58.81%
Industry forward P/E	17.12x
Industry P/E	27.78x
Lynch fair value	EUR 1.99
Lynch upside	-41.74%
P/(FCF - SBC) ratio	5.95x
P/(OCF - SBC) ratio	5.19x
P/B ratio	1.04x
P/E ratio	7.66x
P/FCF ratio	5.93x
P/OCF ratio	5.17x
P/S ratio	1.7x
Price / tangible book value	6.68x
Price/EBITDA ratio	5.51x
Sector forward P/E	14.8x
Sector P/E	39.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	28.37%
EBITDA margin	30.85%
FCF margin	28.87%
Gross margin	61.17%
Operating margin	28.37%
Pretax margin	18.78%
Profit margin	19.82%
Profit per employee	EUR 27,959
Profitable quarters	5
Profitable years	14
Revenue per employee	EUR 141,039
ROA	6.31%
ROA (5Y)	5.77%
ROCE	11.29%
ROE	13.16%
ROE (5Y)	13.89%
ROIC	12.16%
ROIC (5Y)	12.29%
SBC / revenue	0.14%
Tax / revenue	-0.95%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	127.95%
EPS growth (Q)	4.54%
EPS growth (QoQ)	28.97%
EPS growth 10Y	1.04%
EPS growth 3Y	-0.71%
EPS growth 5Y	3.38%
EPS growth quarters	4
EPS growth years	0
FCF growth	35.75%
FCF growth (Q)	161.2%
FCF growth (QoQ)	68.19%
FCF growth 3Y	18.65%
FCF growth 5Y	29.19%
Gross profit growth	44.33%
Gross profit growth (Q)	11.48%
Gross profit growth 3Y	1.82%
Gross profit growth 5Y	11.46%
Net income growth	136.17%
Net income growth (Q)	15.24%
Net income growth (QoQ)	41.12%
Net income growth 3Y	0.26%
Net income growth 5Y	4%
Net income growth quarters	4
Net income growth years	0
OCF growth	18.49%
OCF growth (Q)	85.02%
OCF growth (QoQ)	57.27%
OCF growth 10Y	15.57%
OCF growth 3Y	11.89%
OCF growth 5Y	18.95%
Operating income growth	188.15%
Operating income growth (Q)	3.69%
Operating income growth 3Y	-1.15%
Operating income growth 5Y	11.32%
Revenue growth	32.38%
Revenue growth (Q)	8.49%
Revenue growth (QoQ)	15.81%
Revenue growth 10Y	10.92%
Revenue growth 3Y	2.93%
Revenue growth 5Y	12.46%
Revenue growth quarters	4
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -62.6M
Depreciation and amortization	EUR 36.8M
EBIT	EUR 422.7M
EBITDA	EUR 459.7M
EPS	EUR 0.45
Financing cash flow	EUR -334.6M
Free cash flow	EUR 427.7M
Free cash flow minus SBC	EUR 425.7M
Gross profit	EUR 911.4M
Income taxes	EUR -14.1M
Investing cash flow	EUR -92.3M
Net borrowing	EUR -228.2M
Net cash flow	EUR 63.3M
Net income	EUR 295.4M
Operating cash flow minus SBC	EUR 488.2M
Operating income	EUR 422.7M
Revenue	EUR 1.5B
Stock-based compensation	EUR 2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.78
Book value per share	EUR 3.46
Debt / EBITDA	2.76
Debt / equity	0.53
Debt / FCF	3.04
Goodwill	EUR 1.2B
Interest coverage	2.4
Long-term assets	EUR 3.3B
Long-term liabilities	EUR 1.3B
Net cash (debt)	EUR -1B
Net cash / market cap	-40.73%
Net debt / EBITDA	2.25
Net debt / equity	0.42
Net debt / FCF	2.41
Piotroski F-Score	8
Property, plant and equipment	EUR 736.8M
Shareholders' equity	EUR 2.4B
Tangible book value	EUR 379.4M
Tangible book value per share	EUR 0.54
Total assets	EUR 4.3B
Total cash	EUR 266.7M
Total debt	EUR 1.3B
Total liabilities	EUR 1.8B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.36
Current assets	EUR 998.1M
Current liabilities	EUR 537.2M
Current ratio	1.86
Inventory turnover	1.7
Net working capital	EUR 259.9M
Quick ratio	1.2
Working capital	EUR 463.5M
Working capital turnover	0.76

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-3.61%
Dividend growth	18.5%
Dividend growth (10Y)	3.66%
Dividend growth (3Y)	6.23%
Dividend growth (5Y)	4.15%
Dividend growth years	1
Dividend payment years	11
Dividend payout frequency	Quarterly
Dividend per share	EUR 0.15
Dividend yield	4.43%
Ex-dividend date	2026-10-05
Last dividend	EUR 0.03
Payout ratio	42.92%
Shareholder yield	0.82%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-52.7%
10Y return CAGR	-4.13%
10Y total return	-34.39%
150-day SMA	EUR 3.69
1D price change	1.79%
1M price change	-11.86%
1M total return	-11.25%
1W price change	-24.67%
1W total return	-24.67%
20-day SMA	EUR 4.29
200-day SMA	EUR 3.69
3M price change	3.01%
3M total return	3.72%
3Y price change	-47.38%
3Y return CAGR	-16.52%
3Y total return	-41.82%
50-day SMA	EUR 3.92
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 4.84
52-week high date	2026-10-19
52-week low	EUR 2.98
52-week low date	2025-12-30
5Y price change	-11.86%
5Y return CAGR	0.25%
5Y total return	1.26%
6M price change	-11.4%
6M total return	-10.1%
All-time high	EUR 10.10
All-time high date	2022-10-31
All-time low	EUR 2.60
All-time low date	2025-02-04
Average true range (ATR)	EUR 0.29
Average volume	217.7
Change from 52-week high	-29.34%
Change from 52-week low	14.77%
Change from all-time high	-66.14%
Change from all-time low	31.54%
Change from open	3.01%
Day's gap	-1.19%
High price	EUR 3.48
Low price	EUR 3.32
Monthly RSI	41.94
Open price	EUR 3.32
Position in 52-week range	62.5%
Previous close	EUR 3.36
Price vs 150-day SMA	-7.24%
Price vs 20-day SMA	-20.24%
Price vs 200-day SMA	-7.34%
Price vs 50-day SMA	-12.84%
Relative volume	17.23
RSI	35.72
Sharpe ratio	-0.04
Sharpe ratio (3Y)	0.01
Sharpe ratio (5Y)	0.35
Sortino ratio	0.01
Sortino ratio (3Y)	0.09
Sortino ratio (5Y)	0.6
Weekly RSI	42.59
YTD price change	14.77%
YTD total return	18.55%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	305.7M
Shares change (QoQ)	9.42%
Shares change (YoY)	3.61%
Shares held by insiders	26.05%
Shares held by institutions	25.52%

Deeper analysis on BST/HM6A

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BST/HM6A report

Is a complete BST/HM6A research report available?

No complete published report is available for bst/HM6A (BST/HM6A) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BST/HM6A (BST/HM6A)

Price

Financial snapshot

Fair-value bridge

Latest news · BST/HM6A

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BST/HM6A indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BST/HM6A

Frequently asked questions